Search bioRxiv⌕ Search

Biology subjects

Akao, M.

Publications and source records attributed to Akao, M..

2 recordsLinked to original sources

Oleuropein stimulates peripheral serotonin secretion via voltage-dependent Ca2+ channels and acutely regulates central function

Serotonin (5-HT) is a monoamine which regulates not only central functions but also various peripheral functions. Peripheral 5-HT is primarily derived from the gut, and its synthesis and secretion are regulated by enterochromaffin cells. Stimulation of enterochromaffin cells by food factors may regulate mental functions via the gut-brain axis. We studied whether oleuropein, an olive-derived polyphenol, regulates central functions by stimulating 5-HT secretion from enterochromaffin cells. In QGP-1 cells, which are enterochromaffin-like cells, 10 {micro}M oleuropein stimulated 5-HT secretion via Ca2+ influx through T-type and L-type voltage-dependent Ca2+ channels. Hydroxytyrosol, a metabolite of oleuropein, also promoted 5-HT secretion via the same mechanism. Furthermore, oleuropein stimulated 5-HT secretion from isolated mouse colon via voltage-dependent Ca2+ channels. Finally, oral administration of 200 mg/kg oleuropein acutely increased the depression-like behavior in the mice, which was inhibited by the prior administration of ramosetron, a 5-HT3 receptor antagonist. These findings suggest that oleuropein is a potent stimulant of gut 5-HT secretion, and show that food factors may act to regulate mental function via the secretion of gut 5-HT.

animal behavior and cognition↗

Modeling viral shedding and symptom outcomes in oseltamivir-treated experimental influenza infection

Influenza remains a global public health concern, and although the antiviral drug oseltamivir is widely used to treat infections, questions regarding its actual antiviral efficacy and clinical benefits remain. Here, we evaluated the effects of oseltamivir on viral shedding dynamics in the context of experimental influenza infection. We analyzed individual participant data, including viral load, time to symptom alleviation, and laboratory test measurements, obtained from three publicly available clinical trials involving experimental infections with influenza A and B viruses. We applied mathematical modeling and estimated parameters using a nonlinear mixed-effects model to capture viral infection dynamics. Our analysis revealed that, compared with placebo groups, the oseltamivir-treated groups tended to have lower values in terms of viral load area under the curve, duration of infection, peak viral titer, and time to peak; however, most of these differences were not significant; and no dose-dependent effects were observed. Moreover, there was no significant correlation between time to symptom alleviation and viral load. Some laboratory test parameters showed opposing correlations with symptom-related and viral load-related outcomes. These findings are consistent with distinct mechanisms underlying the symptom-alleviating effects of oseltamivir and its antiviral activity. Our findings suggest that the availability of individual-level data for public use is essential because it enables the evaluation of mechanisms in clinical trials and the development of more appropriate outcome measures.

microbiology↗